Clinical Trial Update: Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describing ongoing recruitment for a study evaluating whether semaglutide improves depressive symptoms in adults with major depr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Nordsjaellands Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: RECRUITING